Tag: research

Generate:Biomedicines
United States

Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

SOMERVILLE, Mass. – Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion of Lisa Wyman to Chief Technical Operations Officer. These appointments not only enhance the company’s leadership team, but also reflect its commitment to gender diversity, with over half of the leadership team represented by women. White’s arrival and Wyman’s promotion are … Continue reading Generate: Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

Impact Newswire
Scenic Biotech
Europe

Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Bristol Myers Squibb gains access to Scenic’s Cell-Seq technology platform to unlock the underlying genetic interactions of cellular pathways for undisclosed targets Scenic to receive an upfront payment and potential additional payments contingent on the achievement of research, development and commercial milestones AMSTERDAM – Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into … Continue reading Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Impact Newswire
CEL-SCI
United States

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Mario Gobbo to its Board of Directors. “This is an exciting and extremely important moment to join the board of CEL-SCI as it is on the brink of developing a product that will revolutionize certain head and neck cancer therapies and probably other deadly cancers. I am proud and honored to become part of the … Continue reading CEL-SCI Appoints Mario Gobbo to Its Board of Directors

Impact Newswire
KBI Biopharma
United States

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

DURHAM, N.C.–(BUSINESS WIRE)–KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI’s Executive Team. “JB’s appointment underscores this dedication, perfectly aligning with our team’s mission to deliver innovative, top-tier solutions tailored to our customers’ evolving needs. His servant leadership philosophy will further fortify … Continue reading KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Impact Newswire
BioCT
United States

BioCT Welcomes Mike Stow of Medtronic to Its Board of Directors

NEW HAVEN, Conn.–(BUSINESS WIRE)–BioCT, Connecticut’s life sciences trade association, is thrilled to announce the appointment of Mike Stow, Vice President of Global Marketing for Robotic Surgical Technologies in the Surgical business of Medtronic, a global leader in healthcare technology, to its Board of Directors. With over 15 years of experience in the medical technologies sector, Mike brings a wealth of knowledge and leadership to the … Continue reading BioCT Welcomes Mike Stow of Medtronic to Its Board of Directors

Impact Newswire
Univo IRB
United States

Julie Blasingim Promoted to Chief Executive Officer of Univo IRB

RALEIGH, N.C. – Univo IRB, a next generation institutional review board (IRB) backed by QHP Capital, today announced Julie Blasingim has been promoted to CEO by Univo’s board of directors. As CEO, Blasingim will drive Univo IRB’s strategic growth and innovation, bringing a modern iteration of IRB solutions to unify patients and research, and support today’s clinical trials. Julie Blasingim will lead @UnivoIRB through its next chapter … Continue reading Julie Blasingim Promoted to Chief Executive Officer of Univo IRB

Impact Newswire
VAST
United States

Space Executive Clay Mowry Joins Vast as Advisor

LONG BEACH, Calif.–(BUSINESS WIRE)–Vast, a pioneer in space habitation technologies, announces the appointment of Clay Mowry as its newest Advisor. “I am excited to join Vast as an Advisor and contribute to the company’s mission of advancing commercial space stations”Post this Mowry’s career spans over two decades in the commercial launch, satellite, and space station sectors. As President of the International Astronautical Federation (IAF), Mowry … Continue reading Space Executive Clay Mowry Joins Vast as Advisor

Impact Newswire
BioConsortia
United States

BioConsortia secures $15 million in latest funding round

Funding global pipeline development of transformational nitrogen-fixing and nematicidal seed treatment products, and extending BioConsortia’s gene-editing leadership position April 01, 2024 10:12 AM Eastern Daylight Time DAVIS, Calif.–(BUSINESS WIRE)–BioConsortia, Inc., a leading agricultural technology company that discovers, designs and licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, today announced that the Company has closed an internal financing round … Continue reading BioConsortia secures $15 million in latest funding round

Impact Newswire
Gilead Sciences
United States

Gilead Sciences Announces Completion of Acquisition of CymaBay

Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases March 22, 2024 09:18 AM Eastern Daylight Time FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in total equity value. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of … Continue reading Gilead Sciences Announces Completion of Acquisition of CymaBay

Impact Newswire